J Mitra & Co Pvt Ltd

J Mitra & Co Pvt Ltd Medical Devices,Immunology,Biotechnology Founded in 1969, the creation of the diagnostic kit division of J. Mitra & Co. Pvt. Ltd. is intimately linked with life. J.

Since then the company has seen a sterling and harmonious growth, achieving recognition that extended far beyond its frontiers. is the pioneer in the production and marketing of medical diagnostic kits in India. It became the first company in India to get the DML (Drug Manufacturing License) for HIV, HBV & HCV Rapid and Elisa test. It also became the first company in India reputed for introducing the HIV TRI-DOT, which has a differential detection system for HIV-1 & HIV-2. The company being fully conscious of the responsibility imposed on it by the nature of its products has given paramount importance to the quality of its products. Quality checks begin at the raw material stage itself and strengthen as every finished product is passed through stages of preliminary analysis and departmental evaluation before eventual commercialization. products being licensed by Drug Authorities, Government of India – a testimony of the company’s credibility and dedication to quality. takes pride in its experiences, qualified and innovative staff and resources. They are constantly seeking newer ways to improve the quality of the products. Enabling them in their endeavor is the sprawling research laboratory well-equipped with the most advanced instruments and equipment needed to run a well-coordinated and systematic R&D program. The R&D center at J. is recognized by the Ministry of Science and Technology, Government of India, since 1988. Thus the company is in a constant pursuit of the betterment of human life with its international standards of production coupled with the reputation gained over many years of superior performance and serving the mankind. Our Values:
• Uncompromised Quality
• Continuous Self-Renewal
• Continuous Innovation
• Positivity
• Winning Spirit

Our Philosophy:
• In the business of preserving human life of critically unwell, through technology and innovation
• Continuous progress via creativity, dreams and imagination. Never being satisfied
• To work hard and enjoy it. To have best productivity of employee compared to others in a similar business activity
• Opportunity for all to achieve, based on the merit not on gender, religion, caste or creed

Typhi IgM iClia is a chemiluminescent microparticle immunoassay designed for in vitro qualitative detection of typhoid I...
18/09/2026

Typhi IgM iClia is a chemiluminescent microparticle immunoassay designed for in vitro qualitative detection of typhoid IgM antibodies in human serum or plasma and is used as a screening
Learn More...

https://zurl.co/PV1OO

Typhi IgM iClia is a chemiluminescent microparticle immunoassay designed for in vitro qualitative detection of typhoid IgM antibodies in human serum or plasma and is used as a screening test for testing of collected blood samples suspected for typhoid infection. This kit is only operational in conju...

FSH iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of Follicle Stimulat...
18/09/2026

FSH iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of Follicle Stimulating Hormone (FSH) in human serum and plasma. The assay kit is intended for

Learn More...

https://zurl.co/KbJbC

FSH iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of Follicle Stimulating Hormone (FSH) in human serum and plasma. The assay kit is intended for in vitro diagnostic use. This kit is only operational in conjunction with J. Mitra CLIA Analyzer.

18/09/2026

The Advantage Chikungunya IgM Card by J. Mitra & Co. provides a rapid, high-precision solution for the qualitative detection of Chikungunya-specific IgM antibodies in human serum, plasma, or whole blood. Based on an advanced sandwich immunoassay principle, this device empowers clinicians to differentiate Chikungunya from similar febrile illnesses like dengue or malaria.

Read Morehttps://zurl.co/3tOU2
#

World Patient Safety Day is observed annually on September 17, focusing this year on the theme "Safe care for noncommuni...
17/09/2026

World Patient Safety Day is observed annually on September 17, focusing this year on the theme "Safe care for noncommunicable diseases" with the official slogan “Safe care for life!”

On World Patient Safety Day 2026, we stand together to champion safe, continuous, and high-quality care for everyone living with noncommunicable diseases (NCDs) like diabetes, cardiovascular conditions, and chronic illnesses. From accurate diagnoses to safe medication practices, every right step protects a life.

Read More...
https://zurl.co/6GmR3

AFP iClia is intended for the in vitro quantitative measurement of alpha fetoprotein (AFP) in human serum/plasma. This k...
17/09/2026

AFP iClia is intended for the in vitro quantitative measurement of alpha fetoprotein (AFP) in human serum/plasma. This kit is only operational with J.Mitra CLIA Analyzer.

Learn More...

https://zurl.co/2sv11

AFP iClia is intended for the in vitro quantitative measurement of alpha fetoprotein (AFP) in human serum/plasma. This kit is only operational with J.Mitra CLIA Analyzer.

Testosterone iCLIA Kit is intended for the in vitro quantitative measurement of testosterone in human serum/plasma, as a...
17/09/2026

Testosterone iCLIA Kit is intended for the in vitro quantitative measurement of testosterone in human serum/plasma, as an aid in the diagnosis of diseases related to abnormal

Learn More...

https://zurl.co/xciqt

Testosterone iCLIA Kit is intended for the in vitro quantitative measurement of testosterone in human serum/plasma, as an aid in the diagnosis of diseases related to abnormal testosterone level in conjunction with other laboratory and clinical findings. This kit is only operational in conjunction wi...

CEA iClia Kit is intended for the in vitro quantitative measurement of carcinoembryonic antigen (CEA) in human serum/pla...
16/09/2026

CEA iClia Kit is intended for the in vitro quantitative measurement of carcinoembryonic antigen (CEA) in human serum/plasma as an aid in clinical observation, prognostic and recurrence

Learn More...

https://zurl.co/X0nQp

CEA iClia Kit is intended for the in vitro quantitative measurement of carcinoembryonic antigen (CEA) in human serum/plasma as an aid in clinical observation, prognostic and recurrence monitoring of malignant tumor. This kit is only operational with J. Mitra CLIA Analyzer.

E2 iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of E2 (Estradiol) in ...
16/09/2026

E2 iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of E2 (Estradiol) in human serum/plasma, as an aid in the diagnosis of ovarian disease

Learn More...

https://zurl.co/u9hFh

E2 iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of E2 (Estradiol) in human serum/plasma, as an aid in the diagnosis of ovarian disease in conjunction with other laboratory and clinical findings. The assay kit is intended for in vitro diagnostic use....

CA-125 iClia is intended for the in vitro quantitative measurement of Cancer Antigen 125 (CA-125) in human serum/plasma ...
15/09/2026

CA-125 iClia is intended for the in vitro quantitative measurement of Cancer Antigen 125 (CA-125) in human serum/plasma as an aid in treatment monitoring of ovarian cancer. This kit is only

Learn More...

https://zurl.co/wptn2

-125iClia

CA-125 iClia is intended for the in vitro quantitative measurement of Cancer Antigen 125 (CA-125) in human serum/plasma as an aid in treatment monitoring of ovarian cancer. This kit is only operational with J. Mitra CLIA Analyzer.

PROLACTIN iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of PROLACTIN (...
15/09/2026

PROLACTIN iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of PROLACTIN (PRL) in human serum and plasma.

Learn More...

https://zurl.co/mxrCL

PROLACTIN iClia is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of PROLACTIN (PRL) in human serum and plasma. The assay kit is intended for in vitro diagnostic use. This kit is only operational in conjunction with CLIA-181 Analyzer.

Address

A-180, Okhla Phase 1
Delhi
110020

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm
Saturday 9am - 5:30pm

Telephone

911126810133

Alerts

Be the first to know and let us send you an email when J Mitra & Co Pvt Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to J Mitra & Co Pvt Ltd:

Shortcuts

Share